HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹254 Cr | ₹233 Cr | ₹198 Cr | ₹114 Cr | ₹97 Cr |
What is the latest Total Non-Current Liabilities ratio of HESTER BIOSCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹254 Cr |
Mar2023 | ₹233 Cr |
Mar2022 | ₹198 Cr |
Mar2021 | ₹114 Cr |
Mar2020 | ₹97 Cr |
How is Total Non-Current Liabilities of HESTER BIOSCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹254 Cr | 9.01 | |
Mar2023 | ₹233 Cr | 17.61 | |
Mar2022 | ₹198 Cr | 73.99 | |
Mar2021 | ₹114 Cr | 17.67 | |
Mar2020 | ₹97 Cr | - |
Compare Total Non-Current Liabilities of peers of HESTER BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HESTER BIOSCIENCES | ₹1,530.0 Cr | -0.9% | 1.2% | -24% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
HESTER BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HESTER BIOSCIENCES | -0.9% |
1.2% |
-24% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses